BLOOD COAGULATION & HEMORRHAGIC DISEASE

血液凝固

基本信息

  • 批准号:
    3337890
  • 负责人:
  • 金额:
    $ 15.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1981
  • 资助国家:
    美国
  • 起止时间:
    1981-09-30 至 1991-06-30
  • 项目状态:
    已结题

项目摘要

The overall and long term goals of the proposed research is an increased understanding of the mechanisms involved in fibrinogen biosynthesis. Particular emphasis and interest is directed at the understanding of those mechanisms and components involved in controlling the synthesis of plasma fibrinogen by parenchymal cells of the liver. Our recent studies indicate that rat fibrinogen fragment D90 (FDP-D90) (90,000 daltons) in micro molar concentrations directly and specifically induces the synthesis of fibrinogen by isolated hepatocytes in a chemically-defined, serum-free medium. Particular attention will be directed to identify and define the receptor on the hepatocyte responsible for the binding of FDP-D90. Additional studies will be performed to identify if this peptide is internalized and if the individual genes are stimulated to express increased quantities of mRNA for the Aalpha, B beta and gamma chains respectively by utilization of the appropriate genomic C-DNA probes. We will identify if cyclic nucleotides, cAMP, adenylate cyclase and Interleukin 1, protein kinase c, Ca++, and clamodulin are mediators of this synthetic path. Since it is possible that FDP-D90 may synergistically act with a "cofactor," detailed studies have been proposed to identify, isolate and purify this component and identify its cell of origin. Because we have recently demonstrated that human fibrinogen fragments D94 (94,000 daltons) and D78 (78,000 daltons) induce striking morphologic abnormalities in vascular endothelial cells, we propose continuation of these studies to identify the mechanisms involved. Expansion of the binding studies in progress will include verification of stimulation of cyclic AMP via adenylate cyclase. We will also measure secretion of prostacyclin and tissue plasminogen activator by Factor VIII:Ag and thrombomodulin to learn if these components that modulate thrombogenesis are disturbed by these fragments of fibrinogen. These comprehensive studies will provide new information on how rat fibrinogen FDP-D90 specifically induces the stimulation of the biosynthesis of fibrinogen and how human fibrinogen FDP-D78 and D94 induce damage in vascular endothelial cells.
拟议研究的总体和长期目标是一个

项目成果

期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Abrupt reversal of gestational autoimmune thrombocytopenia after delivery. A case report.
分娩后妊娠期自身免疫性血小板减少症突然逆转。
Heparin requirement for the quantitation of fibrinogen production by primary hepatocyte cultures.
原代肝细胞培养物中纤维蛋白原产生定量所需的肝素。
  • DOI:
    10.1016/0003-2697(88)90658-6
  • 发表时间:
    1988
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Dang,CV;LaDuca,FM;Bell,WR
  • 通讯作者:
    Bell,WR
Extensive thrombus formation with heparin resistance during extracorporeal circulation. A new presentation of familial antithrombin III deficiency.
体外循环期间出现肝素抗性的广泛血栓形成。
  • DOI:
  • 发表时间:
    1987
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nielsen,LE;Bell,WR;Borkon,AM;Neill,CA
  • 通讯作者:
    Neill,CA
Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution.
纤维蛋白原西雅图 II:先天性纤维蛋白原异常血症,带有 Arg(A α 16)----他的替代品。
  • DOI:
    10.1016/0049-3848(86)90040-x
  • 发表时间:
    1986
  • 期刊:
  • 影响因子:
    7.5
  • 作者:
    Ebert,RF;Schreiler,WE;Bell,WR
  • 通讯作者:
    Bell,WR
The fibrinolytic system in man.
人体的纤溶系统。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WILLIAM R JR BELL其他文献

WILLIAM R JR BELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WILLIAM R JR BELL', 18)}}的其他基金

STRUCTURE-FUNCTION STUDIES OF FIBRINOGEN
纤维蛋白原的结构功能研究
  • 批准号:
    3351093
  • 财政年份:
    1987
  • 资助金额:
    $ 15.16万
  • 项目类别:
STRUCTURE-FUNCTION STUDIES OF FIBRINOGEN
纤维蛋白原的结构功能研究
  • 批准号:
    3351096
  • 财政年份:
    1987
  • 资助金额:
    $ 15.16万
  • 项目类别:
STRUCTURE-FUNCTION STUDIES OF FIBRINOGEN
纤维蛋白原的结构功能研究
  • 批准号:
    3351097
  • 财政年份:
    1987
  • 资助金额:
    $ 15.16万
  • 项目类别:
STRUCTURE-FUNCTION STUDIES OF FIBRINOGEN
纤维蛋白原的结构功能研究
  • 批准号:
    3351098
  • 财政年份:
    1987
  • 资助金额:
    $ 15.16万
  • 项目类别:
STRUCTURE-FUNCTION STUDIES OF FIBRINOGEN
纤维蛋白原的结构功能研究
  • 批准号:
    3351095
  • 财政年份:
    1987
  • 资助金额:
    $ 15.16万
  • 项目类别:
BLOOD COAGULATION & HEMORRHAGIC DISEASE
血液凝固
  • 批准号:
    3337887
  • 财政年份:
    1981
  • 资助金额:
    $ 15.16万
  • 项目类别:
BLOOD COAGULATION AND HEMORRHAGIC DISEASE
凝血和出血性疾病
  • 批准号:
    3337888
  • 财政年份:
    1981
  • 资助金额:
    $ 15.16万
  • 项目类别:
BLOOD COAGULATION & HEMORRHAGIC DISEASE
血液凝固
  • 批准号:
    3337889
  • 财政年份:
    1981
  • 资助金额:
    $ 15.16万
  • 项目类别:

相似海外基金

The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
  • 批准号:
    MR/X032809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.16万
  • 项目类别:
    Fellowship
In depth proteomics-based dynamic profiling of blood proteins for colorectal cancer early detection
基于深度蛋白质组学的血液蛋白动态分析用于结直肠癌早期检测
  • 批准号:
    21K07408
  • 财政年份:
    2021
  • 资助金额:
    $ 15.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Blood Proteins for early Discrimination of dEmentias
用于早期识别痴呆症的血液蛋白
  • 批准号:
    nhmrc : 1191861
  • 财政年份:
    2020
  • 资助金额:
    $ 15.16万
  • 项目类别:
    International Collaborations
Nanomaterial based enrichment of blood proteins for cancer detection and monitoring
基于纳米材料的血液蛋白富集用于癌症检测和监测
  • 批准号:
    299939
  • 财政年份:
    2013
  • 资助金额:
    $ 15.16万
  • 项目类别:
    Studentship Programs
SGER: Separation and Purification of High Molecular Weight Homologous Blood Proteins using IMAC
SGER:使用 IMAC 分离和纯化高分子量同源血液蛋白
  • 批准号:
    9904465
  • 财政年份:
    1999
  • 资助金额:
    $ 15.16万
  • 项目类别:
    Standard Grant
STRUCTURES OF CATALYTIC DOMAINS OF BLOOD PROTEINS
血液蛋白催化域的结构
  • 批准号:
    6248438
  • 财政年份:
    1997
  • 资助金额:
    $ 15.16万
  • 项目类别:
STRUCTURES OF CATALYTIC DOMAINS OF BLOOD PROTEINS
血液蛋白催化域的结构
  • 批准号:
    6258867
  • 财政年份:
    1997
  • 资助金额:
    $ 15.16万
  • 项目类别:
STRUCTURES OF CATALYTIC DOMAINS OF BLOOD PROTEINS
血液蛋白催化域的结构
  • 批准号:
    2911249
  • 财政年份:
    1996
  • 资助金额:
    $ 15.16万
  • 项目类别:
STRUCTURES OF CATALYTIC DOMAINS OF BLOOD PROTEINS
血液蛋白催化域的结构
  • 批准号:
    3361806
  • 财政年份:
    1991
  • 资助金额:
    $ 15.16万
  • 项目类别:
STRUCTURES OF CATALYTIC DOMAINS OF BLOOD PROTEINS
血液蛋白催化域的结构
  • 批准号:
    3361805
  • 财政年份:
    1991
  • 资助金额:
    $ 15.16万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了